BioHealth News
Cartesian Therapeutics Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for Descartes-08 for the Treatment of Myasthenia Gravis
GAITHERSBURG, Md., May 22, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company pioneering mRNA cell therapy for…
Read MoreWelldoc Certified as a Great Place to Work® for Third Year in a Row
COLUMBIA, Md., May 21, 2024 — Welldoc®, a leading digital health company specializing in AI-driven cardiometabolic health, announced today that it was Certified™ by Great Place…
Read MoreSave the Dates: 2024 BioHealth Capital Region Week Registration Coming Soon
Looking forward to the Autumn of 2024, the BioHealth Capital Region is gearing up for three major events, September 17th, 18th, and 19th, 2024,…
Read MoreGaithersburg’s Amplexd Therapeutics, Innovating to Revolutionize the Future of Non-Invasive HPV-induced Cervical Intraepithelial Neoplasia (CIN) Treatments for the Prevention of Cervical Cancer: Developed by Women for Women
GAITHERSBURG, MD, May 20, 2024 (GLOBE NEWSWIRE) -- Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in accessible…
Read MoreBaltimore Fishbowl: MCB Real Estate announces plans for a mixed-use development in Montgomery County that will have a focus on the life sciences and biohealth
MCB Real Estate, the developer of Harborplace in Baltimore, announced on Thursday that it will lead the development of VIVA White Oak, a mixed…
Read MoreVanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness
WASHINGTON, May 15, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the results from its second Phase III study of tradipitant in motion sickness,…
Read MoreSands Capital’s Pulse Fund III Secures $555M Close
The Life Sciences Pulse strategy partners with private companies helping transform how diseases are defined, diagnosed, and treated. Sands Capital is pleased to announce…
Read MoreMaryland Stem Cell Research Commission Announces $15.4 Million in Awards to Accelerate Cures
48 scientists receive funding from the Maryland Stem Cell Research Fund to further research COLUMBIA, Md. (May 14, 2024)—The Maryland Stem Cell Research Commission…
Read MoreNextStep Robotics Wins Pitch Dingman Competition Grand Prize, Announces New Board Members
BALTIMORE, MD – May 13, 2024 – NextStep Robotics, a University of Maryland, Baltimore (UMB) spinout company dedicated to commercializing cutting-edge stroke rehabilitation technologies,…
Read MoreLinshom Medical Chosen by the NIH to Attend the Angel Capital Association Annual Meeting
BALTIMORE, MD, US, May 10, 2024 - Linshom Medical, a Maryland based start-up medical device company was selected as one of eight companies to represent…
Read MoreNovavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine and Develop Novel COVID-19-Influenza Combination Vaccines
GAITHERSBURG, Md., May 10, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, has entered into a co-exclusive licensing agreement with Sanofi…
Read MoreKite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
REDWOOD CITY, Calif. & SANTA MONICA, Calif.--(BUSINESS WIRE)-- Kite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates…
Read MoreDanaher Launches Collaboration with Johns Hopkins University Aiming to Improve Neurological Diagnosis
WASHINGTON, May 9, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator ("Danaher"), today launched a collaboration with Johns Hopkins University aiming to develop…
Read MoreWelldoc Named “Best Overall Digital Health Company” for Second Consecutive Year in the 8th Annual MedTech Breakthrough Awards Program
COLUMBIA, Md., May 9, 2024 — Welldoc®, a leading digital health company specializing in cardiometabolic health, today announced that it has been selected as winner of the “Best Overall…
Read MoreStem Cell Research Shines at Maryland Stem Cell and Regenerative Medicine Tech Showcase
COLUMBIA, MD (May 8, 2024) – Maryland’s leading edge in stem cell research was on full display at the Maryland Stem Cell and Regenerative…
Read More